View Older Stories View More Recent Stories

Jan 8, 2024 04:15PM Form SC 13G/A 4D Molecular Therapeutic Filed by: VIKING GLOBAL INVESTORS LP
Jan 8, 2024 04:05PM Form SC 13G/A 4D Molecular Therapeutic Filed by: VIKING GLOBAL INVESTORS LP
Jan 5, 2024 05:45PM Form 4 4D Molecular Therapeutic For: Jan 04 Filed by: Viking Global Opportunities GP LLC
Jan 4, 2024 08:00AM HI-Bio Announces $95 Million Series B Financing to Advance Targeted Therapies for Immune-Mediated Diseases
Jan 2, 2024 09:56PM Form 144 APi Group Corp Filed by: VIKING GLOBAL INVESTORS LP
Dec 19, 2023 10:00AM Lightmatter Accelerates Growth and Expands Photonic Chip Deployments With $155M in New Funding; Now Valued at $1.2B
Dec 19, 2023 07:00AM Ayana Bio Welcomes Industry Veteran Jim Hamilton to its Board of Directors
Dec 12, 2023 05:31PM Madryn Asset Management, a Top Shareholder of SomaLogic, Issues Letter Regarding Opposition to the Company’s Proposed Merger with Standard BioTools
Dec 12, 2023 11:45AM Battelle, Revive Environmental to Demonstrate PFAS Technology in Department of Defense Project
Dec 8, 2023 04:11PM Form SC 13D/A Cazoo Group Ltd Filed by: VIKING GLOBAL INVESTORS LP
Dec 8, 2023 09:00AM Alveolus Bio Enters Into Strategic Collaboration with BiomEdit
Nov 22, 2023 04:16PM Form SC 13D/A STANDARD BIOTOOLS INC. Filed by: VIKING GLOBAL INVESTORS LP
Nov 22, 2023 04:15PM Form SC 13D/A Cazoo Group Ltd Filed by: VIKING GLOBAL INVESTORS LP
Nov 22, 2023 04:15PM Form SC 13D/A BridgeBio Pharma, Inc. Filed by: VIKING GLOBAL INVESTORS LP
Nov 14, 2023 03:10PM Form 13F-HR VIKING GLOBAL INVESTORS For: Sep 30
Nov 7, 2023 04:11PM Form SC 13D/A Cazoo Group Ltd Filed by: VIKING GLOBAL INVESTORS LP
Nov 2, 2023 04:33PM Form SC 13G Viking Therapeutics, Filed by: VIKING GLOBAL INVESTORS LP
Oct 31, 2023 09:00AM Pearl Health Releases Annual Report and Survey Findings on the State of Primary Care
Oct 26, 2023 06:00AM Triveni Bio Launches with $92 Million Series A Financing to Advance Genetics-Informed Precision Medicines for the Treatment of Immunological and Inflammatory (I&I) Disorders
Oct 24, 2023 08:00AM DermBiont Announces First Close of $35.2 Million in a Series B Financing to Advance First-in-Class Targeted Topical Dermatological Therapeutics
Oct 23, 2023 07:00AM Ayana Bio Launches Plant Cell Advantage™ Portfolio with Three New Health and Wellness Ingredients
Oct 16, 2023 04:30PM Form SC 13D STANDARD BIOTOOLS INC. Filed by: VIKING GLOBAL INVESTORS LP
Oct 16, 2023 07:00AM Survey data reveals two-thirds of American adults would eat more and pay more for ultra-processed foods that include more nutritious ingredients
Oct 6, 2023 04:15PM Form SC 13G Five9, Inc. Filed by: VIKING GLOBAL INVESTORS LP
Oct 6, 2023 07:36AM Form D/A Viking Global Opportunit
Oct 6, 2023 07:26AM Form D/A Viking Global Equities
Oct 6, 2023 07:18AM Form D/A Viking Global Opportunit
Oct 6, 2023 07:05AM Form D/A Viking Global Equities
Oct 6, 2023 06:55AM Form D/A Viking Global Equities
Sep 28, 2023 08:04AM AI startup AlphaSense valued at $2.5 billion after latest funding round
Sep 28, 2023 08:00AM AlphaSense Grows to $2.5 Billion Valuation, Securing $150 Million in Series E Funding Led by BOND
Sep 27, 2023 11:35AM Battelle Ranked Fifth on Fortune’s 2023 Change the World List for Its PFAS Annihilator® Technology
Sep 26, 2023 08:17AM Mythic Therapeutics Receives FDA Fast Track Designation for MYTX-011 for Patients with Non-Small Cell Lung Cancer (NSCLC) with cMET Overexpression
Sep 22, 2023 05:25PM Form SC 13D/A Cazoo Group Ltd Filed by: VIKING GLOBAL INVESTORS LP
Sep 21, 2023 05:11PM Form SC 13G RayzeBio, Inc. Filed by: VIKING GLOBAL INVESTORS LP
Sep 21, 2023 05:01PM Form 4 RayzeBio, Inc. For: Sep 19 Filed by: Viking Global Opportunities Drawdown Portfolio GP LLC
Sep 19, 2023 08:17AM Mythic Therapeutics to Present New Preclinical Data on MYTX-011, Investigational cMET-Targeting Antibody-Drug Conjugate (ADC), at the AACR-NCI-EORTC International Conference on Molecular Targets and C
Sep 14, 2023 09:46PM Form 3 RayzeBio, Inc. For: Sep 14 Filed by: VIKING GLOBAL INVESTORS LP
Sep 14, 2023 09:45PM Form 3 RayzeBio, Inc. For: Sep 14 Filed by: VIKING GLOBAL INVESTORS LP
Sep 12, 2023 06:02AM Walgreens Boots Alliance (WBA) and Pearl Health Announce Strategic Partnership to Advance Value-Based Care Delivery
Sep 12, 2023 06:00AM Walgreens and Pearl Health Announce Strategic Partnership to Advance Value-Based Care Delivery
Aug 30, 2023 08:45PM Form 4 Inhibrx, Inc. For: Aug 28 Filed by: VIKING GLOBAL INVESTORS LP
Aug 29, 2023 09:01AM Inhibrx Inc. (INBX) Announces $200M Financing at $19.35/sh
Aug 29, 2023 09:00AM Inhibrx Announces $200 Million Private Placement Financing
Aug 24, 2023 04:30PM Form SC 13G VALVOLINE INC Filed by: VIKING GLOBAL INVESTORS LP
Aug 14, 2023 04:25PM Form 13F-HR VIKING GLOBAL INVESTORS For: Jun 30
Aug 9, 2023 12:06AM Hedge fund Viking reopens flagship fund after decade -sources
Jul 26, 2023 09:03AM Patina teams with Humana to expand reach of convenient, relationship-centered primary care for people with Medicare
Jul 20, 2023 06:02AM Form SC 13D/A BridgeBio Pharma, Inc. Filed by: VIKING GLOBAL INVESTORS LP
Jul 19, 2023 09:34PM Form 4 BridgeBio Pharma, Inc. For: Jul 18 Filed by: VIKING GLOBAL INVESTORS LP
View More Recent Stories View Older Stories